Pramirol 0.25 Tablet is a prescription drug, available for use as Tablet. It is primarily used for the treatment of Parkinson's Disease. Pramirol 0.25 Tablet also has some secondary and off-label uses. These are listed below.
The optimal dosage of Pramirol 0.25 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Some other side effects of Pramirol 0.25 Tablet have been listed ahead. Normally, these side effects of Pramirol 0.25 Tablet are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Pramirol 0.25 Tablet is Moderate for pregnant women and Severe for women who are breastfeeding. Further, the section on Pramirol 0.25 Tablet related warnings talks about Pramirol 0.25 Tablet's effects on the liver, heart and kidney.
Pramirol 0.25 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Pramirol 0.25 Tablet in conditions like Schizophrenia, Heart Disease, Kidney Disease.
Drug interactions for Pramirol 0.25 Tablet have been reported in the medical literature. See below for a complete list.
You should also be aware that Pramirol 0.25 Tablet is not safe while driving, and is not addiction.
Pramirol 0.25 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Pramirol 0.25 Tablet safe for pregnant women?
Pramirol can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Pramirol right away. Take your doctor's advice before taking it again.
Is the use of Pramirol 0.25 Tablet safe during breastfeeding?
Taking Pramirol may lead to serious side effects if you are breastfeeding. Pramirol should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Pramirol 0.25 Tablet on the Kidneys?
Pramirol rarely affects the kidneys.
What is the effect of Pramirol 0.25 Tablet on the Liver?
Pramirol does not damage the liver.
What is the effect of Pramirol 0.25 Tablet on the Heart?
Pramirol is rarely harmful for the heart.
Pramirol 0.25 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Pramirol 0.25 Tablet unless your doctor advises you to do so -
Is this Pramirol 0.25 Tablet habit forming or addictive?
Forming a habit of Pramirol 0.25 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Pramirol 0.25 Tablet, you should not drive or work on any heavy machine, as Pramirol 0.25 Tablet can make you drowsy.
Is it safe?
Yes, but consume Pramirol 0.25 Tablet only on doctor's advice.
Is it able to treat mental disorders?
Yes, in many cases, taking Pramirol 0.25 Tablet can help with mental disorders.
Interaction between Food and Pramirol 0.25 Tablet
Pramirol 0.25 Tablet may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Pramirol 0.25 Tablet
Consumption of alcohol and Pramirol 0.25 Tablet together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Mirapex® (pramipexole dihydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1043-1044
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 430-431